Log in
ASX:HLS

Healius Limited (HLS.AX) Stock Forecast, Price & News

Add
Compare
Today's Range N/A
50-Day Range
A$2.39
MA: A$2.39
A$2.39
52-Week Range N/A
Volume2.33 million shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend Yield1.73%
BetaN/A
Healius Limited provides facilities and support services to independent general practitioners, radiologists, and other healthcare professionals in Australia. The company operates through three segments: Pathology, Imaging, and Day Hospitals. It offers diagnostic imaging services, including X-ray, ultrasound, computerized tomography, mammography, magnetic resonance imaging, nuclear medicine, positron emission tomography, and interventional radiology; and private medical laboratory and pathology services. The company also provides cataract surgery, colonoscopy, gastroscopy, plastic and cosmetic surgery, skin, cancer removal, IVF egg collection, and gynaecological surgery services. It operates 2,234 pathology sites; 15 day hospital sites; and 146 imaging sites. The company was formerly known as Primary Health Care Limited and changed its name to Healius Limited in December 2018. Healius Limited was incorporated in 1994 and is based in St Leonards, Australia.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.7Dividend Strength: 0.8Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.71 out of 5 stars

Industry, Sector and Symbol

Industry Medical Care
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone61 2 9432 9400
EmployeesN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$1.60 billion
Book ValueA$3.10 per share

Profitability

Miscellaneous

Next Earnings DateN/A
OptionableNot Optionable

Receive HLS News and Ratings via Email

Sign-up to receive the latest news and ratings for HLS and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Healius Limited (HLS.AX) (ASX:HLS) Frequently Asked Questions

How were Healius Limited (HLS.AX)'s earnings last quarter?

Healius Limited (HLS.AX) (ASX:HLS) announced its earnings results on Friday, February, 15th. The company reported $0.04 earnings per share for the quarter, missing the Zacks' consensus estimate of $0.09 by $0.06.
View Healius Limited (HLS.AX)'s earnings history
.

How often does Healius Limited (HLS.AX) pay dividends? What is the dividend yield for Healius Limited (HLS.AX)?

Healius Limited (HLS.AX) declared a Interim dividend on Thursday, February 27th. Shareholders of record on Wednesday, April 15th will be paid a dividend of 0.026 per share on Wednesday, April 15th. This represents a yield of 0.84%. The ex-dividend date of this dividend is Thursday, March 26th.
View Healius Limited (HLS.AX)'s dividend history
.

Who are some of Healius Limited (HLS.AX)'s key competitors?

What other stocks do shareholders of Healius Limited (HLS.AX) own?

Who are Healius Limited (HLS.AX)'s key executives?

Healius Limited (HLS.AX)'s management team includes the following people:
  • Dr. Malcolm W. Parmenter B.S., M.A.I.C.D., M.S., MD, CEO & Director (Age 65, Pay $1.64M)
  • Ms. Maxine Jacquet, Chief Financial Officer
  • Mr. Dean Lewsam, Chief Exec. of Imaging
  • Mr. John McKechnie, Chief Exec. of the Pathology Division
  • Mr. Peter Wilson, Group Exec. of People & Shared Services (Age 60)

What is Healius Limited (HLS.AX)'s stock symbol?

Healius Limited (HLS.AX) trades on the ASX under the ticker symbol "HLS."

How big of a company is Healius Limited (HLS.AX)?

Healius Limited (HLS.AX) has a market capitalization of $0.00 and generates $1.60 billion in revenue each year. Healius Limited (HLS.AX) employs 12,500 workers across the globe.

What is Healius Limited (HLS.AX)'s official website?

The official website for Healius Limited (HLS.AX) is www.primaryhealthcare.com.au.

How can I contact Healius Limited (HLS.AX)?

The company can be reached via phone at 61 2 9432 9400.

This page was last updated on 10/24/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.